BSECompany Update8 Aug 2026 · 8 Aug 2026, 02:41 pm
Monitoring Agency Report for the Quarter ended 30th June, 2026
J.G.Chemicals Ltd · 544138
✦ AI SummaryResults
J.G.Chemicals Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations, indicating no deviation from the objects of the issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
J.G.Chemicals Ltd - 544138 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
829103b2-a12d-418a-a9e9-448cd4e91127.pdf
View document text
08th August, 2026
To, To,
The Manager, The General Manager,
Listing Department, Department of Corporate Services,
National Stock Exchange of India Ltd, BSE Ltd.,
Exchange Plaza, 1st Floor, New Trading Ring,
Plot No. – C – 1, G Block, Rotunda Building,
Bandra – Kurla Complex, P.J. Towers,
Bandra (East), Dalal Street, Fort,
Mumbai – 400051 Mumbai – 400001
NSE Code – JGCHEM BSE Code – 544138
Dear Sir,
Subject: Disclosure under Regulation 32 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 - Monitoring Agency Report for the
Quarter ended June 30, 2026
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended, Regulation 41 of the SEBI (Issue of Capital and Disclosure
Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report
dated August 04, 2026, issued by ICRA Limited, Monitoring Agency, for the quarter ended
June 30, 2026 in respect of utilisation of proceeds of the Initial Public Offer of the Company.
This disclosure will also be hosted on the Company's website viz. www.jgchem.com .
Kindly take the same on record.
Yours faithfully,
For J.G.Chemicals Limited
Swati Poddar
Company Secretary and Compliance Officer
Encl.: as Above
J. G. Chemicals Limited
(An ISO 9001, 14001, 45001 CERTIFIED COMPANY)
Adventz Infinity@5, Unit No. 1511, Street No. 18, BN Block, Sector – V, Salt Lake City, Kolkata – 700 091, India,
Phone: +91 33 4415 0100
Email: cs@jgchem.com | Web: www.jgchem.com
Mfg. of: “LUXMI” (UR) BRAND ZINC OXIDE
CIN: L24100WB2001PLC093380
Date: August 04, 2026
Mr. Anuj Jhunjhunwala
Chief Financial Officer and Executive Director
J.G. Chemicals Limited
Adventz Infinity@ 5,
Unit No. 1511,
Street Number 18, BN Block, Sector V
Salt Lake,
Kolkata – 700091, India
Dear Sir,
Re: Final Monitoring Agency report of J.G. Chemicals Limited for Q1 FY2027
Please refer to agreement dated February 26, 2024, appointing ICRA Limited as the Monitoring
Agency (MA) for J.G. Chemicals Limited’s IPO Issue.
After due consideration, ICRA has prepared the attached final Monitoring Agency report as per SEBI
(Issue of Capital and Disclosure Requirements) Regulations for Q1 FY2027.
Please note that the Monitoring Agency report does not constitute a commentary on the quality of the
objects of the issue, appropriateness or reasonableness of costs or spending by J.G. Chemicals Limited
against any objects / heads or assurance on outcome of such spending.
We thank you for your kind cooperation extended during the course of Q1 FY2027. Should you require
any clarification, please do not hesitate to get in touch with us.
We look forward to your communication and assure you of our best services.
With kind regards
For ICRA Limited
Parul Goyal Narang
Vice President & Head-Process Excellence
parul.goyal@icraindia.com
ICRA Limited
Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel. +91-11-23357940-41
Building No. 8, 2nd floor, Tower A, DLF Cyber City, Phase II, Gurugram-122002
www.icra.in info@icraindia.com +91-93547-38909
+0124-4545300 CIN: L74999DL1991PLC042749
June 2026
MONITORING AGENCY REPORT
Name of the Issuer: J.G. Chemicals Limited
For quarter ended: June 30, 2026
Name of the Monitoring Agency (MA): ICRA Limited
(a) Deviation from the objects of the issue:
No deviation - the utilization of the issuance proceeds is in line with the objects of the issue.
(b) Range of deviation:
Not Applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the
objects of the issue based on the information provided by the Issuer and information obtained from sources believed
by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of
any information/ certifications/ statements it receives. This Report is not intended to create any legally binding
obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said
information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of
the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as
creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report.
The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The
MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report
pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that
we do not perceive any conflict of interest in such relationship/ interest while monitoring and reporting the
utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format
prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the
title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee
of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of
the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no
responsibility for such comments of the issuer’s Management/Board.
Signature:
Digitally signed by
Parul Goyal
Parul Goyal Narang
Narang Date: 2026.08.04
13:02:40 +05'30'
Parul Goyal Narang
Vice President & Head- Process Excellence
Analyst: Arshi Naz
Quality Analyst: Dhwani Vinchhi
Sensitivity Label : Public
June 2026
1. Issuer Details
Name of the Issuer: J.G. Chemicals Limited
Name(s) of the promoters:
Promoters
Suresh Jhunjhunwala
Anirudh Jhunjhunwala
Anuj Jhunjhunwala
Source: BSE
Industry/ sector to which it belongs: Speciality Chemicals
2. Issue Details
Issue Period: Opening date- March 05, 2024
Closing date- March 07, 2024
Type of Issue: Initial Public Offer
Type of specified securities: Equity shares
IPO Grading, if any: No credit rating agency registered with SEBI has been appointed in respect of obtaining grading
for the offer.
Issue Size (Rs. Crore): 251.190
With OFS portion: INR 251.190 Crore
Excluding OFS portion: INR 165.000 Crore.
Net proceeds as per Prospectus: INR 149.324 Crore (Excluding Issue Related Expenses)
Note: ICRA has monitored Gross Proceeds of INR 165.000 crore in Q1 FY2027
Sensitivity Label : Public
June 2026
3. Details of the arrangement made to ensure the monitoring of issue proceeds.
Comments
Source of information,
of the
certifications considered by Comments of the Monitoring
Particulars Reply Issuer’s
the Monitoring Agency for Agency
Board of
the preparation of report
Directors
While the utilisation of funds
-Peer reviewed CA Certificate
remains in line with the objects
-Confirmation from
Whether all utilization is as per outlined in the prospectus, the
management No
the disclosures in the Offer Yes actual spending does not
- Bank statement of the comments
Document? correspond with the vendors’
proceeds account/
specifications as originally
corresponding accounts
proposed.
Whether shareholder approval
has been obtained in case of
Not As confirmed by the Issuer’s No
material deviations# from No comments
Applicable management comments
expenditures disclosed in the
Offer Document?
Whether the means of finance
As confirmed by the Issuer’s No
for the disclosed objects of the No No comments
management comments
issue has changed?
Is there any major deviation
observed over the earlier No No deviation observed. No comments
comments
monitoring agency reports?
Civil/construction work related to
Whether all Government/
R&D Unit have already started and
statutory approvals related to As confirmed by the Issuer’s in process till the quarter ended No
the object(s) have been management 30th June, 2026 and also, we have comments
[Showing first 8,000 characters — download PDF for full document]